Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP342503.RARCofvV9HrbfA4ssP-xsgdU8EfLNXzOvBCfeFkv7d_MI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP342503.RARCofvV9HrbfA4ssP-xsgdU8EfLNXzOvBCfeFkv7d_MI130_assertion type Assertion NP342503.RARCofvV9HrbfA4ssP-xsgdU8EfLNXzOvBCfeFkv7d_MI130_head.
- NP342503.RARCofvV9HrbfA4ssP-xsgdU8EfLNXzOvBCfeFkv7d_MI130_assertion wasGeneratedBy ECO_0000203 NP342503.RARCofvV9HrbfA4ssP-xsgdU8EfLNXzOvBCfeFkv7d_MI130_provenance.
- NP342503.RARCofvV9HrbfA4ssP-xsgdU8EfLNXzOvBCfeFkv7d_MI130_assertion wasDerivedFrom befree-2016 NP342503.RARCofvV9HrbfA4ssP-xsgdU8EfLNXzOvBCfeFkv7d_MI130_provenance.
- NP342503.RARCofvV9HrbfA4ssP-xsgdU8EfLNXzOvBCfeFkv7d_MI130_assertion SIO_000772 11802201 NP342503.RARCofvV9HrbfA4ssP-xsgdU8EfLNXzOvBCfeFkv7d_MI130_provenance.
- NP342503.RARCofvV9HrbfA4ssP-xsgdU8EfLNXzOvBCfeFkv7d_MI130_assertion evidence source_evidence_literature NP342503.RARCofvV9HrbfA4ssP-xsgdU8EfLNXzOvBCfeFkv7d_MI130_provenance.
- NP342503.RARCofvV9HrbfA4ssP-xsgdU8EfLNXzOvBCfeFkv7d_MI130_assertion description "[Two cell lines were engineered to overexpress hyal-1: a breast cancer line (CAL51) and a prostate cancer line (PC3M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP342503.RARCofvV9HrbfA4ssP-xsgdU8EfLNXzOvBCfeFkv7d_MI130_provenance.